Jeffrey Mitchell

LexaGene Holdings has appointed Jeffrey Mitchell as its chief financial officer effective immediately. 

Mitchell has more than two decades of financial and SEC experience, LexaGene said. Before joining the firm, he served in positions of increasing responsibility for Palomar Medical Technologies, including controller, director of finance, and supervisor of public-company financial reporting, audits, and financial planning and analysis.

He replaced Zula Kropivnitski.